Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | Patient advocacy in the treatment journey

Anita Waldmann • 24 Mar 2019
EBMT 2019
General CAR-T

Anita Waldmann, of Leukaemia Patient-Support Group RHEIN-MAIN, Ruesselsheim am Main, Germany, talks about how patient advocacy groups are useful tools for patients in the cancer treatment journey. Ms Waldmann mentions how they bring to the table a new aspect, patient input, regarding novel therapies, in order to help HCPs appreciate the patient’s point of view. Recorded at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Anita Waldmann

1:13
The future of the EBMT patient advocacy track
Anita Waldmann • 24 Mar 2019
1:08
The 1st patient advocacy track at EBMT: making a difference for patients
Anita Waldmann • 24 Mar 2019
2:58
The role of the Worldwide Network for Blood & Marrow Transplantation (WBMT)
Anita Waldmann • 18 Mar 2018
3:33
Giving attention to the needs and voices of bone and marrow transplant patients
Anita Waldmann • 18 Mar 2018

Related Videos

5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals